Personalis, Inc. (PSNL) Balance Sheet

The balance sheet shows a pattern of periodic equity infusions followed by steady erosion from operating losses. The $120.7M jump in equity between Q2 and Q3 2025 suggests a dilutive capital raise, yet by Q2 2026 equity had already declined by $26.0M, indicating a quarterly burn of roughly $13M. This trajectory implies that without sustained revenue growth, the company will require additional financing within the next few quarters, potentially at unfavorable terms.

The company's debt is modest relative to equity and assets, and the D/E ratio has improved steadily, reflecting both debt repayment and equity raises. However, the absolute debt level of $38.0M, combined with negative operating cash flow, suggests that debt service is not a near-term concern but could become one if cash reserves deplete. The low leverage provides some cushion, but the company's ability to refinance or access additional credit may be constrained by its loss-making profile.

The asset base is dominated by cash and working capital, with PP&E relatively stable around $60-70M, suggesting a lab infrastructure that is not expanding rapidly. The absence of goodwill and intangibles is notable, implying that growth has been organic and that there is no impairment risk from acquisitions. However, the high cash balance is deceptive because it is being consumed at a rapid pace, and the fixed asset base may require upgrades to support the reported clinical volume growth, which could pressure future cash flows.

The equity base is of low quality, as it is primarily composed of paid-in capital from dilutive raises rather than retained earnings. The cumulative deficit of $693.0M underscores the company's history of losses, and the recent equity raise suggests that management is prioritizing liquidity over shareholder value. Stock-based compensation, though not shown on the balance sheet, likely contributes to ongoing dilution, and investors should monitor the share count growth as a key risk.

The current ratio is exceptionally high, indicating ample short-term assets to cover liabilities, but this is largely due to the cash balance. However, the cash burn rate of approximately $25-30M per quarter suggests that the current cash position provides only a limited runway, especially if revenue growth does not accelerate. The company may need to raise additional capital within the next year, which could be dilutive given the current market conditions.